 |
|
Clinical Effect of Intravitreal Bevacizumab Injection in Myopic Choroidal Neovascularization.
Kyong Ho Kim, Jae Ho Jung, Ji Eun Lee, Boo Sup Oum
J Korean Ophthalmol Soc. 2010;51(3):359-365. Published online 2010 Mar 15 DOI: https://doi.org/10.3341/jkos.2010.51.3.359
|
|
Citations to this article as recorded by
 Safety Evaluation of Bilateral Same-day Intravitreal Injections of Bevacizumab
Kyu Hwan Jang, Ja Young Ahn, Joon Hong Sohn, Daniel Duck-Jin Hwang
Journal of the Korean Ophthalmological Society.2020; 61(10): 1164. CrossRef Long-term Treatment Outcomes of Intravitreal Bevacizumab Treatment for Myopic Choroidal Neovascularization
Jeong Min Lee, Jong Woo Kim, Dong Won Lee, Jae Hui Kim
Journal of the Korean Ophthalmological Society.2019; 60(6): 547. CrossRef Comparison of Two Doses of IVB and Prognostic Factor on Myopic CNV : 1-Year Outcome
Eun Hae Lim, Yoon Soo Jang, Young Ju Lew, Su Jin Yoo
Journal of the Korean Ophthalmological Society.2012; 53(12): 1807. CrossRef Long-term Therapeutic Effect of Intravitreal Bevacizumab (Avastin) on Myopic Choroidal Neovascularization
Young Seung Seo, Moo Hwan Chang
Journal of the Korean Ophthalmological Society.2011; 52(1): 34. CrossRef
|